期刊文献+

心脏生物起搏器的应用进展

Research progress in biological pacemakers
下载PDF
导出
摘要 背景:生物起搏器不需要更换电池,可接近磁场,对体内神经递质有自动反应性,有望成为临床治疗心脏传导系统疾病的一种有效方法。目的:从基因治疗、细胞移植、激素治疗3方面总结生物起搏器的构建方法。方法:以"生物起搏器"为检索词,应用计算机检索2000-03/2009-03万方数据库的相关文章,并限定文章语言种类为中文;同时计算机检索2000-03/2009-03PubMed数据库相关文章,检索词为"biologicalpacemaker",并限定文章语言种类为English。共检索到105篇文章,最终纳入符合标准的25篇文献进行综述。结果与结论:目前,生物起搏器的构建主要有基因转导、细胞移植与激素治疗3种方法。生物"起搏器"的研究还处于动物实验研究阶段,将它应用于临床实践中还有很多问题需要研究和解决,如怎样获得高效、安全的基因转染载体,细胞移植的最佳部位,起搏功能的调控及免疫排斥反应的处理等。随着细胞生物学、细胞电生理学、分子生物学及基因工程技术的飞速发展,现阶段存在的问题会逐步得到解决,相信心脏生物起搏器将成为临床治疗心脏传导系统疾病的一种有效方法。 BACKGROUND:Biological pacemakers need not replace battery,can approach magnetic field,and has automatic reaction to the neurotransmitter inside the body.It is an effective method to treat cardiac conduction system disease.OBJECTIVE:From gene treatment,cell transplantation,hormone curing to acquaint the methods of building biological pacemakers.METHODS:Using "biological pacemaker" as a keyword in Chinese and English,a computer-based search of Wanfang and PubMed databases(2000-03/2009-03) was conducted to retrieve relevant articles.Among the 105 retrieved articles,25 articles were included in result analysis.RESULTS AND CONCLUSION:Currently,there are three kinds of methods to build biological pacemakers:gene transfection,cell transplantation and hormone cure.The research of biological pacemaker is still placed in the animal experimental step,and it has a long way to go until the biological pacemakers can be used clinically,such as how to acquire safe and efficient gene vectors,the best part for cell transplantation,how to adjust the pacing function and how to handle the immunity reject reaction,etc.We believe according to the developing of cell biology,cell electricity physiology,molecular biology and genetic engineering technology,the problems that exist currently will gradually be settled and biologic pacemakers will become an effective way to treat cardiac conduction system disease.
作者 田野 张陈匀
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第45期8533-8536,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献25

  • 1Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002;40(9):1703-1719.
  • 2Kaupp UB, Seifert R. Molecular diversity of pacemaker ion channels. Annu Rev Physiol. 2001;63:235-57.
  • 3Qu J, Plotnikov AN, Danilo P Jr, et al. Expression and function of a biological pacemaker in canine heart. Circulation. 2003;107(8): 1106-1109.
  • 4Plotnikov AN, Sosunov EA, Qu J, et al. Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation. 2004;109(4):506-512.
  • 5Glenn CM, Pogwizd SM. Gene therapy to develop a genetically engineered cardiac pacemaker. J Cardiovasc Nurs. 2003;18(5): 330-336.
  • 6Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest. 2003;111(10): 1529-1536.
  • 7Silva J, Rudy Y. Mechanism of pacemaking in I(K1)-downregulated myocytes. Circ Res. 2003;92(3):261-263.
  • 8Edelberg JM, Aird WC, Rosenberg RD. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest. 1998;101(2):337-343.
  • 9Edelberg JM, Huang DT, Josephson ME, et al. Molecular enhancement of porcine cardiac chronotropy. Heart. 2001; 86(5): 559-562.
  • 10Rosen MR, Robinson RB, Brink P, et al. Recreating the biological pacemaker. Anat Rec A Discov Mol Cell Evol Biol. 2004;280(2): 1046-1052.

二级参考文献18

  • 1金艳,曹克将.骨髓干细胞心肌移植进展及其致心律失常可能[J].中国心脏起搏与心电生理杂志,2004,18(6):480-482. 被引量:8
  • 2任晓庆,浦介麟,张澍,贾玉和,吴国玫,孟亮,王方正.自体骨髓间叶干细胞诱导分化移植治疗房室阻滞的初步观察[J].中国心脏起搏与心电生理杂志,2005,19(1):48-52. 被引量:17
  • 3Hughes HC. Swine in cardiovascular research[J]. Lab Anim Sci, 1986, 36(7):348.
  • 4Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion[J]. Nature, 2002, 416: 542.
  • 5Ying QL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion[J]. Nature, 2002, 416: 545.
  • 6Kehat I, Dorit KK, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional propertiel of cardiomyocytes[J]. J Clin lnvest. 2001, 108(2):407.
  • 7He JQ, Ma Y, Lee YS, et al. Human embryonic stem cells develop into multiple types of cardiac myocytes-action potential characterization[J]. Circ Res, 2003, 90:32.
  • 8Johkura K, Cui L, Suzuki A, et al. Survival and function of mouse embryonic stem cell-derived cardiomyocytes in ectopic transplants[J]. Cardiovasc Res, 2003, 58(10):435.
  • 9Reffelmann T, Dow JS, Dai WD, et al. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infracted myocardium[J]. J Mol Cell Cardiol, 2003, 35(7):60.
  • 10Muller-Ehmsen J, Peterson KL, Kedes L, et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function[J]. Circulation, 2002, 105(9):1 720.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部